Cannabidiol 100 MG/ML

DRUG3 trials

Sponsors

Zealand University Hospital, Hugo W. Moser Research Institute at Kennedy Krieger, Inc., Laboratorio Elea Phoenix S.A.

Conditions

AnxietyChemotherapy-induced Peripheral NeuropathyEpilepsyParkinson Disease

Phase 2

Cannabidiol for Prevention of Chemotherapy-induced Peripheral Neuropathy

Zealand University HospitalChemotherapy-induced Peripheral Neuropathy

Start: 2021-03-03End: 2023-08-30Updated: 2022-02-08

Clinical Trial with Cannabidiol (Kanbis®) for Parkinson Disease Symptoms

RecruitingNCT06629389

Laboratorio Elea Phoenix S.A.Parkinson Disease

Start: 2024-11-28End: 2026-11-30Target: 88Updated: 2024-12-05

Phase 4

Epidiolex® for Anxiety in Pediatric Epilepsy

CompletedNCT05324449

Hugo W. Moser Research Institute at Kennedy Krieger, Inc.Anxiety, Epilepsy

Start: 2022-04-05End: 2025-05-05Updated: 2025-07-02